Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

5.42USD
5:42pm GMT
Change (% chg)

$0.12 (+2.26%)
Prev Close
$5.30
Open
$5.30
Day's High
$5.42
Day's Low
$5.20
Volume
37,941
Avg. Vol
75,454
52-wk High
$6.68
52-wk Low
$4.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.05 0.10 0.03 0.03
Quarter Ending Mar-19 3 0.05 0.10 0.03 --
Year Ending Dec-18 3 0.48 0.50 0.46 13.19
Year Ending Dec-19 3 0.18 0.30 0.12 5.14
Earnings (per share)
Quarter Ending Dec-18 3 -0.19 -0.18 -0.20 -0.22
Quarter Ending Mar-19 3 -0.17 -0.10 -0.22 --
Year Ending Dec-18 3 -0.77 -0.76 -0.78 -0.55
Year Ending Dec-19 3 -0.81 -0.64 -0.90 -0.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.62 33.60
P/E High - Last 5 Yrs. -- 301.03 45.05
P/E Low - Last 5 Yrs. -- 83.19 24.37
Beta -- 0.93 0.91
Price to Sales (TTM) -- 119.20 5.69
Price to Book (MRQ) -- 14.53 5.11
Price to Tangible Book (MRQ) -- 13.73 6.54
Price to Cash Flow (TTM) -- 65.35 23.53
% Owned Institutions -- 13.41 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.48
Dividend Yield - 5 Year Avg -- 0.33 1.50
Dividend 5 Year Growth Rate -- 2.84 5.08
Payout Ratio(TTM) -- 25.28 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 376.86 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 95.69 5.86
Sales - 5 Yr. Growth Rate -- 28.71 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 28.13 21.20
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 32.53 10.63
Capital Spending - 5 Yr. Growth Rate -- 35.83 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.10 2.26
Current Ratio (MRQ) -- 5.34 3.09
LT Debt to Equity (MRQ) -- 35.90 11.53
Total Debt to Equity (MRQ) -- 37.76 15.71
Interest Coverage (TTM) -- -89.20 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.11 54.07
Gross Margin - 5 Yr. Avg. -- 48.16 51.83
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -543.12 11.80
Operating Margin (TTM) -- -781.99 4.84
Operating Margin - 5 Yr. Avg. -- -563.67 7.45
Pre-Tax Margin (TTM) -- -746.11 5.82
Pre-Tax Margin - 5 Yr. Avg. -- -568.92 7.86
Net Profit Margin (TTM) -- -747.08 2.07
Net Profit Margin - 5 Yr. Avg. -- -571.62 4.10
Effective Tax Rate (TTM) -- 25.08 23.39
Effective Tax Rate - 5 Yr. Avg. -- 20.19 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,492,720 905,570,157
Net Income/Employee (TTM) -- 826,541 107,319,415
Receivable Turnover (TTM) -- 19.51 5.95
Inventory Turnover (TTM) -- 2.77 3.63
Asset Turnover (TTM) -- 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -2.02 11.52
Return on Assets - 5 Yr. Avg. -- 2.44 12.71
Return on Investment (TTM) -- -0.65 15.05
Return on Investment - 5 Yr. Avg. -- 1.25 16.50
Return on Equity (TTM) -- 0.07 16.62
Return on Equity - 5 Yr. Avg. -- 1.76 17.61

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.